IC
ROIV icon

Ikarian Capital’s Roivant Sciences ROIV Stock Holding History

Ikarian Capital’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-100,609
Closed -$1.16M – 200
2024
Q3 		$1.16M Hold
100,609
– – 0.16% 91
2024
Q2 		$1.06M Hold
100,609
– – 0.19% 74
2024
Q1 		$1.06M Sell
100,609
-51,212
-34% -$552K 0.12% 104
2023
Q4 		$1.7M Buy
151,821
+150,000
+8,237% +$1.46M 0.16% 89
2023
Q3 		$21.3K Sell
1,821
-223,179
-99% -$2.52M ﹤0.01% 135
2023
Q2 		$2.27M Sell
225,000
-350,000
-61% -$3.13M 0.36% 61
2023
Q1 		$4.24M Buy
+575,000
New +$4.73M 0.96% 38

Other funds holding ROIV

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Ikarian Capital's ROIV Position: Q4 2024 in Review

Ikarian Capital sold out of Roivant Sciences (ROIV) in Q4 2024, closing a stake of 100,609 shares — an estimated $1.16M sold.

Ikarian Capital first reported a position in ROIV in Q1 2023 and held it in 7 quarters. The position peaked at $4.24M in Q1 2023. 318 funds tracked by Wall St. Rank hold ROIV as of Q4 2024.

  • Ikarian Capital reported no remaining Roivant Sciences position as of Q4 2024 after selling out during the quarter.
  • Ikarian Capital sold 100,609 Roivant Sciences shares in Q4 2024, an estimated $1.16M.
  • Ikarian Capital first reported a position in Roivant Sciences in Q1 2023 and held it in 7 quarters.
  • Ikarian Capital's Roivant Sciences position peaked at $4.24M in Q1 2023.
  • 318 funds tracked by Wall St. Rank held Roivant Sciences as of Q4 2024.

Based on Ikarian Capital's 13F filing for Q4 2024, filed 14 Feb 2025.